Nuzenio

Pharmacyte Biotech

Pharmacyte Biotech news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 5 publisher sources 100/100 entity strength

Latest news

PharmaCyte Biotech Inc (PMCB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Sat, 08 Aug 2026 03:23:29 GMTPharmaCyte Biotech (PMCB) Q1 2026 Earnings: Narrowing Loss Amid Clinical Progress - Earnings Forecast Report - dars.gov.etdars.gov.et · Fri, 31 Jul 2026 01:42:45 GMTPharmaCyte Biotech (PMCB) Q1 2026 Earnings: Narrowing Loss Amid Clinical Progress - Healthcare Earnings Report - dars.gov.etdars.gov.et · Fri, 31 Jul 2026 01:34:36 GMTTop Companies Developing Cell Therapy Treatments For Diabetes in 2026 - BioInformantBioInformant · Thu, 30 Jul 2026 07:00:00 GMTPharmaCyte Biotech, Inc. FY 2026: Revenue $0 Net income ($23.21M), EPS ($2.77) — 10-K Summary - TradingViewTradingView · Wed, 29 Jul 2026 21:05:01 GMTPharmaCyte Biotech, Inc. Reports Earnings Results for the Full Year Ended April 30, 2026 - marketscreener.commarketscreener.com · Wed, 29 Jul 2026 07:00:00 GMTPharmaCyte Biotech Inc (PMCB) Financial Health: Profitability & Balance Sheet Analysis - TradingKeyTradingKey · Mon, 27 Jul 2026 14:34:38 GMTPharmaCyte Biotech Inc (PMCB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKeyTradingKey · Mon, 27 Jul 2026 01:49:43 GMT

Timeline

Sat, 08 Aug 2026 03:23:29 GMTPharmaCyte Biotech Inc (PMCB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Fri, 31 Jul 2026 01:42:45 GMTPharmaCyte Biotech (PMCB) Q1 2026 Earnings: Narrowing Loss Amid Clinical Progress - Earnings Forecast Report - dars.gov.et
Fri, 31 Jul 2026 01:34:36 GMTPharmaCyte Biotech (PMCB) Q1 2026 Earnings: Narrowing Loss Amid Clinical Progress - Healthcare Earnings Report - dars.gov.et
Thu, 30 Jul 2026 07:00:00 GMTTop Companies Developing Cell Therapy Treatments For Diabetes in 2026 - BioInformant
Wed, 29 Jul 2026 21:05:01 GMTPharmaCyte Biotech, Inc. FY 2026: Revenue $0 Net income ($23.21M), EPS ($2.77) — 10-K Summary - TradingView
Wed, 29 Jul 2026 07:00:00 GMTPharmaCyte Biotech, Inc. Reports Earnings Results for the Full Year Ended April 30, 2026 - marketscreener.com

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Pharmacyte Biotech.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.